TAF9B Antikörper (AA 1-251)
Kurzübersicht für TAF9B Antikörper (AA 1-251) (ABIN526835)
Target
Alle TAF9B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-251
-
Verwendungszweck
- Rabbit polyclonal antibody raised against a full-length human TAF9B protein.
-
Sequenz
- MESGKMAPPK NAPRDALVMA QILKDMGITE YEPRVINQML EFAFRYVTTI LDDAKIYSSH AKKPNVDADD VRLAIQCRAD QSFTSPPPRD FLLDIARQKN QTPLPLIKPY AGPRLPPDRY CLTAPNYRLK SLIKKGPNQG RLVPRLSVGA VSSKPTTPTI ATPQTVSVPN KVATPMSVTS QRFTVQIPPS QSTPVKPVPA TTAVQNVLIN PSMIGPKNIL ITTNMVSSQN TANEANPLKR KHEDDDDNDI M
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody reactive against mammalian transfected lysate.
-
Immunogen
- TAF9B (NP_057059.2, 1 a.a. ~ 251 a.a) full-length human protein.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
- TAF9B (TAF9B RNA Polymerase II, TATA Box Binding Protein (TBP)-Associated Factor, 31kDa (TAF9B))
-
Andere Bezeichnung
- TAF9B
-
Hintergrund
-
Full Gene Name: TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31 kDa
Synonyms: DN-7,DN7,TAF9L,TAFII31L,TFIID-31 -
Gen-ID
- 51616
-
NCBI Accession
- NM_015975
-
Pathways
- Negative Regulation of intrinsic apoptotic Signaling
Target
-